December 22, 2025 article Open access Optimizing immunotherapy for head and neck squamous cell carcinoma: recent advances and future directions Annals of Medicine DOI: 10.1080/07853890.2025.2603755 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 3 References 2 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma 2021 Nature Communications article Medicine Cancer Immunotherapy and Biomarkers Open access 330 citations [18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma 2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Medical Imaging Techniques and Applications Open access 42 citations 2 results